Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions-Reference-Cited by-同舟云学术

Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions

Published:2011 Issue: Volume:5 Page:47-59
ISSN:1877-282X
Container-title:Procedia in Vaccinology
language:en
Short-container-title:Procedia in Vaccinology

Author:

Isbrucker Richard,Levis Robin,Casey Warren,McFarland Richard,Schmitt Michael,Arciniega Juan,Descamps Johan,Finn Theresa,Hendriksen Coenraad,Horiuchi Yoshinobu,Keller James,Kojima Hajime,Sesardic Dorothea,Stickings Paul,Johnson Nelson W,Allen David

Publisher

Elsevier BV

Subject

Infectious Diseases,Drug Discovery,Pharmaceutical Science,Immunology

Reference68 articles.

1. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). The NICEATM-ICCVAM five-year plan (2008-2012): a plan to advance alternative test methods of high scientific quality to protect and advance the health of people, animals, and the environment. National Institute of Environmental Health Sciences, 2008. NIH Publication No. 08-6410. http://iccvam.niehs.nih.gov/docs/5yearplan.htm.

2. Introduction and summary of the international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: state of the science and future directions;Stokes;Proc Vaccinol,2011

3. Non-animal replacement methods for human vaccine potency testing: state-of-the-science and future directions;McFarland;Proc Vaccinol,2011

4. Non-animal replacement methods for veterinary vaccine potency testing: state-of-the-science and future directions;Kulpa-Eddy;Proc Vaccinol,2011

5. Improving animal welfare and reducing and refining animal use for human vaccine potency testing: state-of-the-science and future directions;Casey;Proc Vaccinol,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot-Scale Production of Lyophilized Inactivated Rabies Vaccine Candidate in Vero Cells under Fully Animal Component-Free Conditions Using Microcarrier Technology and Laboratory Animal Trials;Journal of Biomedical Science and Engineering;2022

2. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein;Journal of Immunological Methods;2021-05

3. Toxicology and Nonclinical Safety Assessment in Pharmaceutical Discovery and Development;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28

4. A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody;Human Vaccines & Immunotherapeutics;2020-01-23

5. Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA;Biologicals;2019-07